Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed

Fernando Membreno, Arturo L. Baez, Reka Pandula, Eric Walser, Daryl T Y Lau

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Objective: To compare the survival after transjugular intrahepatic portosystemic shunt (TIPS) for refractory ascites and variceal bleed, and to identify the factors predictive of survival. Methods: Single tertiary center, retrospective-prospective study. Chart review was performed on all patients who underwent TIPS between 1993 and 2000 and prospective follow-up to determine survival. Pre- and post-TIPS clinical parameters were compared and Kaplan-Meier analysis was applied to compare the survival of both groups. Cox regression was used to identify predictors of survival after TIPS. Results: A total of 163 patients were included, 62 with refractory ascites and 101 with variceal bleed. Both groups had similar age (48.2 vs 48.9 year; P = 0.65) and consisted of predominantly Caucasians (51%) and Mexican-Americans (39%). More than 75% had chronic hepatitis C, alcoholic liver disease or both. Overall, the median survival was significantly better for variceal bleed (2 years) compared with refractory ascites (6 months) (P < 0.001). This survival advantage persisted in patients with Mayo risk score greater than 1.17. Transjugular intrahepatic portosystemic shunt improved severe ascites in 45% of patients (P = 0.03). Mayo risk score was highly predictive of survival afterTIPS with a hazard ratio of 2.3, followed by Child-Pugh score, creatinine, albumin and ethnicity, with better survival among Mexican-Americans. Shunt dysfunction (31%) and hepatic encephalopathy (27%) were the most common complications of TIPS. Conclusions: Patients who received TIPS for variceal bleed had significantly longer survival compared with those for refractory ascites. Mexican-Americans had an improved long-term survival compared with Caucasians. The reason for this ethnic difference in survival is unclear and warrants further prospective evaluation.

Original languageEnglish (US)
Pages (from-to)474-481
Number of pages8
JournalJournal of Gastroenterology and Hepatology (Australia)
Volume20
Issue number3
DOIs
StatePublished - 2005

Fingerprint

Transjugular Intrahepatic Portasystemic Shunt
Ascites
Survival
Alcoholic Liver Diseases
Hepatic Encephalopathy
Kaplan-Meier Estimate
Chronic Hepatitis C
Albumins
Creatinine

Keywords

  • Ascites
  • Portal hypertension
  • Transjugular intrahepatic portosystemic shunt
  • Variceal bleed

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed. / Membreno, Fernando; Baez, Arturo L.; Pandula, Reka; Walser, Eric; Lau, Daryl T Y.

In: Journal of Gastroenterology and Hepatology (Australia), Vol. 20, No. 3, 2005, p. 474-481.

Research output: Contribution to journalArticle

@article{fc91283923304f0f99b06d8235b7a9a4,
title = "Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed",
abstract = "Objective: To compare the survival after transjugular intrahepatic portosystemic shunt (TIPS) for refractory ascites and variceal bleed, and to identify the factors predictive of survival. Methods: Single tertiary center, retrospective-prospective study. Chart review was performed on all patients who underwent TIPS between 1993 and 2000 and prospective follow-up to determine survival. Pre- and post-TIPS clinical parameters were compared and Kaplan-Meier analysis was applied to compare the survival of both groups. Cox regression was used to identify predictors of survival after TIPS. Results: A total of 163 patients were included, 62 with refractory ascites and 101 with variceal bleed. Both groups had similar age (48.2 vs 48.9 year; P = 0.65) and consisted of predominantly Caucasians (51{\%}) and Mexican-Americans (39{\%}). More than 75{\%} had chronic hepatitis C, alcoholic liver disease or both. Overall, the median survival was significantly better for variceal bleed (2 years) compared with refractory ascites (6 months) (P < 0.001). This survival advantage persisted in patients with Mayo risk score greater than 1.17. Transjugular intrahepatic portosystemic shunt improved severe ascites in 45{\%} of patients (P = 0.03). Mayo risk score was highly predictive of survival afterTIPS with a hazard ratio of 2.3, followed by Child-Pugh score, creatinine, albumin and ethnicity, with better survival among Mexican-Americans. Shunt dysfunction (31{\%}) and hepatic encephalopathy (27{\%}) were the most common complications of TIPS. Conclusions: Patients who received TIPS for variceal bleed had significantly longer survival compared with those for refractory ascites. Mexican-Americans had an improved long-term survival compared with Caucasians. The reason for this ethnic difference in survival is unclear and warrants further prospective evaluation.",
keywords = "Ascites, Portal hypertension, Transjugular intrahepatic portosystemic shunt, Variceal bleed",
author = "Fernando Membreno and Baez, {Arturo L.} and Reka Pandula and Eric Walser and Lau, {Daryl T Y}",
year = "2005",
doi = "10.1111/j.1440-1746.2005.03601.x",
language = "English (US)",
volume = "20",
pages = "474--481",
journal = "Journal of Gastroenterology and Hepatology (Australia)",
issn = "0815-9319",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed

AU - Membreno, Fernando

AU - Baez, Arturo L.

AU - Pandula, Reka

AU - Walser, Eric

AU - Lau, Daryl T Y

PY - 2005

Y1 - 2005

N2 - Objective: To compare the survival after transjugular intrahepatic portosystemic shunt (TIPS) for refractory ascites and variceal bleed, and to identify the factors predictive of survival. Methods: Single tertiary center, retrospective-prospective study. Chart review was performed on all patients who underwent TIPS between 1993 and 2000 and prospective follow-up to determine survival. Pre- and post-TIPS clinical parameters were compared and Kaplan-Meier analysis was applied to compare the survival of both groups. Cox regression was used to identify predictors of survival after TIPS. Results: A total of 163 patients were included, 62 with refractory ascites and 101 with variceal bleed. Both groups had similar age (48.2 vs 48.9 year; P = 0.65) and consisted of predominantly Caucasians (51%) and Mexican-Americans (39%). More than 75% had chronic hepatitis C, alcoholic liver disease or both. Overall, the median survival was significantly better for variceal bleed (2 years) compared with refractory ascites (6 months) (P < 0.001). This survival advantage persisted in patients with Mayo risk score greater than 1.17. Transjugular intrahepatic portosystemic shunt improved severe ascites in 45% of patients (P = 0.03). Mayo risk score was highly predictive of survival afterTIPS with a hazard ratio of 2.3, followed by Child-Pugh score, creatinine, albumin and ethnicity, with better survival among Mexican-Americans. Shunt dysfunction (31%) and hepatic encephalopathy (27%) were the most common complications of TIPS. Conclusions: Patients who received TIPS for variceal bleed had significantly longer survival compared with those for refractory ascites. Mexican-Americans had an improved long-term survival compared with Caucasians. The reason for this ethnic difference in survival is unclear and warrants further prospective evaluation.

AB - Objective: To compare the survival after transjugular intrahepatic portosystemic shunt (TIPS) for refractory ascites and variceal bleed, and to identify the factors predictive of survival. Methods: Single tertiary center, retrospective-prospective study. Chart review was performed on all patients who underwent TIPS between 1993 and 2000 and prospective follow-up to determine survival. Pre- and post-TIPS clinical parameters were compared and Kaplan-Meier analysis was applied to compare the survival of both groups. Cox regression was used to identify predictors of survival after TIPS. Results: A total of 163 patients were included, 62 with refractory ascites and 101 with variceal bleed. Both groups had similar age (48.2 vs 48.9 year; P = 0.65) and consisted of predominantly Caucasians (51%) and Mexican-Americans (39%). More than 75% had chronic hepatitis C, alcoholic liver disease or both. Overall, the median survival was significantly better for variceal bleed (2 years) compared with refractory ascites (6 months) (P < 0.001). This survival advantage persisted in patients with Mayo risk score greater than 1.17. Transjugular intrahepatic portosystemic shunt improved severe ascites in 45% of patients (P = 0.03). Mayo risk score was highly predictive of survival afterTIPS with a hazard ratio of 2.3, followed by Child-Pugh score, creatinine, albumin and ethnicity, with better survival among Mexican-Americans. Shunt dysfunction (31%) and hepatic encephalopathy (27%) were the most common complications of TIPS. Conclusions: Patients who received TIPS for variceal bleed had significantly longer survival compared with those for refractory ascites. Mexican-Americans had an improved long-term survival compared with Caucasians. The reason for this ethnic difference in survival is unclear and warrants further prospective evaluation.

KW - Ascites

KW - Portal hypertension

KW - Transjugular intrahepatic portosystemic shunt

KW - Variceal bleed

UR - http://www.scopus.com/inward/record.url?scp=16344382389&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16344382389&partnerID=8YFLogxK

U2 - 10.1111/j.1440-1746.2005.03601.x

DO - 10.1111/j.1440-1746.2005.03601.x

M3 - Article

VL - 20

SP - 474

EP - 481

JO - Journal of Gastroenterology and Hepatology (Australia)

JF - Journal of Gastroenterology and Hepatology (Australia)

SN - 0815-9319

IS - 3

ER -